Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Marbocyl
2. Marbocyl Fd
1. 115550-35-1
2. Marbocyl
3. Zeniquin
4. Marbofloxacine
5. 8x09wu898t
6. 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic Acid
7. 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic Acid
8. Ncgc00166310-01
9. Ro 09-1168
10. Dsstox_cid_26600
11. Dsstox_rid_81755
12. Dsstox_gsid_46600
13. 7h-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic Acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
14. 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-3,7-dihydro-2h-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic Acid
15. Marbofloxacin [inn]
16. Marbofloxacino [inn-spanish]
17. Marbofloxacine [inn-french]
18. Marbofloxacinum [inn-latin]
19. Cas-115550-35-1
20. Marbofloxacin [inn:ban]
21. Unii-8x09wu898t
22. Ccris 8212
23. 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7h-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic Acid
24. 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7h-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic Acid
25. Mfcd00864820
26. Marbofloxacin (usp/inn)
27. Marbofloxacin [mi]
28. Oprea1_079403
29. Marbofloxacin [mart.]
30. Schembl134860
31. Chembl478120
32. Dtxsid4046600
33. Chebi:94723
34. Ex-a015
35. Marbofloxacin [green Book]
36. Zinc537947
37. Hy-b0126
38. Rkl10084
39. Marbofloxacin For Peak Identification
40. Tox21_112406
41. S1464
42. Akos015853291
43. Tox21_112406_1
44. Bcp9000896
45. Ccg-229989
46. Cs-1892
47. Db11426
48. Gs-3323
49. Marbofloxacin 100 Microg/ml In Methanol
50. Ncgc00166310-02
51. Ncgc00166310-03
52. 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic Acid
53. 7h-pyrido(3,2,1-ij)(4,1,2)benzoxadiazine-6-carboxylic Acid, 2,3-dihydro-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
54. 9-fluoro-3,7-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2h-[1,3,4]oxadiazino[6,5,4-ij]quinoline-6-carboxylic Acid
55. Ac-24289
56. Bm164656
57. Db-041275
58. Ft-0628168
59. M2240
60. Marbofloxacin 100 Microg/ml In Acetonitrile
61. D08156
62. H10130
63. Ab01566820_01
64. 550m351
65. Marbofloxacin, Vetranal(tm), Analytical Standard
66. Q909359
67. Sr-01000772975
68. Q-201338
69. Sr-01000772975-2
70. Marbofloxacin, European Pharmacopoeia (ep) Reference Standard
71. Marbofloxacin For Peak Identification, European Pharmacopoeia (ep) Reference Standard
72. 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2- Diazatricyclo[7.3.1.0^5,13^]trideca-5,7,9(13),11-tetraene-11-carboxylic Acid
73. 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.0^{5,13]trideca-5(13),6,8,11-tetraene-11-carboxylic Acid
74. 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.0^{5,13}]trideca-5,7,9(13),11-tetraene-11-carboxylic Acid
75. 7-fluoro-2-methyl-6-(4-methylpiperazin-4-ium-1-yl)-10-oxo-4-oxa-1,2-diazatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylate
76. 7h-1,3,4-oxadiazino[6,5,4-ij]quinoline-6-carboxylic Acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-
77. 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl -1-piperazinyl)-7-oxo-7h-pyrido[3,2,1-ij][4,1,2]benzoxadiazine-6-carboxylic Acid
78. 9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)- 7-oxo-7h-pyrido[1,2,3-ij][1,2,4]benzoxadiazine-6-carboxylic Acid
Molecular Weight | 362.4 g/mol |
---|---|
Molecular Formula | C17H19FN4O4 |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 2 |
Exact Mass | 362.13903326 g/mol |
Monoisotopic Mass | 362.13903326 g/mol |
Topological Polar Surface Area | 76.6 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 636 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 10057
Submission : 1993-01-25
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35484
Submission : 2020-12-31
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : FORCYL
Dosage Form : SOLUTION
Dosage Strength : 160MG/ML
Packaging : 50ML/100ML/250ML
Approval Date :
Application Number : 2474441
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : AURIZON
Dosage Form : SUSPENSION
Dosage Strength : 3MG/ML
Packaging : 10/20/30ML
Approval Date :
Application Number : 2353970
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ZENIQUIN
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging : 50
Approval Date :
Application Number : 2241412
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ZENIQUIN
Dosage Form : TABLET
Dosage Strength : 100MG
Packaging : 50
Approval Date :
Application Number : 2241413
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ZENIQUIN
Dosage Form : TABLET
Dosage Strength : 50MG
Packaging : 100
Approval Date :
Application Number : 2241414
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : ZENIQUIN
Dosage Form : TABLET
Dosage Strength : 25MG
Packaging : 100/250
Approval Date :
Application Number : 2241415
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : South Korea
Brand Name : Maflox 10%
Dosage Form : Injectable
Dosage Strength : 100MG/ML
Packaging : 20ML, 50ML, 100ML, 250ML
Approval Date :
Application Number :
Regulatory Info :
Registration Country : South Korea
Packaging : 20ML, 50ML, 100ML, 250ML
Regulatory Info :
Dosage : Injectable
Dosage Strength : 100MG/ML
Brand Name : Maflox 10%
Approval Date :
Application Number :
Registration Country : South Korea
Regulatory Info :
Registration Country : Poland
Brand Name : MARBOVET®
Dosage Form : Injectable Solution
Dosage Strength : 100MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Poland
Packaging :
Regulatory Info :
Dosage : Injectable Solution
Dosage Strength : 100MG/1ML
Brand Name : MARBOVET®
Approval Date :
Application Number :
Registration Country : Poland
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?